Comparative diagnostic performance of plasma microbial cell-free DNA sequencing versus amplicon-based blood next-generation sequencing in suspected bloodstream or endovascular infection: a single-center study
Summary
No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.
Summarise with VIRAT Free to try with your Science Catalogs account.Abstract
We compared plasma microbial cell-free DNA sequencing (mcfDNAseq) with an amplicon-based blood next-generation sequencing (NGS) assay for 10 patients with suspected bloodstream or endovascular infection. Plasma testing detected pathogens in eight (seven clinically meaningful), whereas amplicon testing was negative in all. Plasma mcfDNAseq provided higher test yield and overall sensitivity.
Fields of Study & Subjects
Bacterial Identification and Susceptibility Testing
Genomics and Phylogenetic Studies
Infective Endocarditis Diagnosis and Management
Publication details
- Journal / source
- Antimicrobial Stewardship & Healthcare Epidemiology
- Volume
- 6
- Issue
- 1
- Pages
- e69–e69
- Publication date
- 27 March 2026
- Language
- EN